Dot/Icm-Dependent Restriction of Legionella pneumophila within Neutrophils.

Christopher T D Price, Hannah E Hanford, Aruna Vashishta, Mateja Ozanic, Marina Santic, Silvia Uriarte, Yousef Abu Kwaik
Author Information
  1. Christopher T D Price: Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, USA.
  2. Hannah E Hanford: Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, USA.
  3. Aruna Vashishta: Department of Medicine, University of Louisville, Louisville, Kentucky, USA.
  4. Mateja Ozanic: University of Rijeka, Rijeka, Croatia.
  5. Marina Santic: University of Rijeka, Rijeka, Croatia.
  6. Silvia Uriarte: Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, USA.
  7. Yousef Abu Kwaik: Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, USA.

Abstract

The Dot/Icm type IV secretion system (T4SS) of Legionella pneumophila is essential for lysosomal evasion and permissiveness of macrophages for intracellular proliferation of the pathogen. In contrast, we show that polymorphonuclear cells (PMNs) respond to a functional Dot/Icm system through rapid restriction of L. pneumophila. Specifically, we show that the L. pneumophila T4SS-injected amylase (LamA) effector catalyzes rapid glycogen degradation in the PMNs cytosol, leading to cytosolic hyperglucose. Neutrophils respond through immunometabolic reprogramming that includes upregulated aerobic glycolysis. The PMNs become activated with spatial generation of intracellular reactive oxygen species within the -containing phagosome (LCP) and fusion of specific and azurophilic granules to the LCP, leading to rapid restriction of L. pneumophila. We conclude that in contrast to macrophages, PMNs respond to a functional Dot/Icm system, and specifically to the effect of the injected amylase effector, through rapid engagement of major microbicidal processes and rapid restriction of the pathogen. Legionella pneumophila is commonly found in aquatic environments and resides within a wide variety of amoebal hosts. Upon aerosol transmission to humans, L. pneumophila invades and replicates with alveolar macrophages, causing pneumonia designated Legionnaires' disease. In addition to alveolar macrophages, neutrophils infiltrate into the lungs of infected patients. Unlike alveolar macrophages, neutrophils restrict and kill L. pneumophila, but the mechanisms were previously unclear. Here, we show that the pathogen secretes an amylase (LamA) enzyme that rapidly breakdowns glycogen stores within neutrophils, and this triggers increased glycolysis. Subsequently, the two major killing mechanisms of neutrophils, granule fusion and production of reactive oxygen species, are activated, resulting in rapid killing of L. pneumophila.

Keywords

References

  1. J Clin Invest. 1980 Sep;66(3):441-50 [PMID: 7190579]
  2. Front Cell Infect Microbiol. 2020 Dec 16;10:581024 [PMID: 33392103]
  3. PLoS Pathog. 2017 Apr 6;13(4):e1006309 [PMID: 28384349]
  4. Infect Immun. 1992 Aug;60(8):3231-7 [PMID: 1322369]
  5. Front Cell Infect Microbiol. 2020 Jun 23;10:214 [PMID: 32656090]
  6. Diabetes Res Clin Pract. 2007 Apr;76(1):44-50 [PMID: 16959366]
  7. Infect Immun. 1998 Sep;66(9):4151-7 [PMID: 9712761]
  8. PLoS Pathog. 2016 Jun 14;12(6):e1005691 [PMID: 27300652]
  9. Front Cell Infect Microbiol. 2017 May 29;7:217 [PMID: 28611952]
  10. Front Immunol. 2014 Sep 26;5:470 [PMID: 25309549]
  11. J Immunol. 2011 Mar 1;186(5):3130-7 [PMID: 21270399]
  12. J Clin Invest. 1984 Jun;73(6):1515-23 [PMID: 6373825]
  13. Front Cell Infect Microbiol. 2020 Aug 20;10:428 [PMID: 32974218]
  14. Ann Intern Med. 1979 Apr;90(4):509-17 [PMID: 434627]
  15. Front Cell Infect Microbiol. 2020 May 29;10:237 [PMID: 32547960]
  16. Mol Microbiol. 1994 Nov;14(3):583-94 [PMID: 7885236]
  17. Immunity. 2015 Mar 17;42(3):419-30 [PMID: 25786174]
  18. Front Cell Infect Microbiol. 2020 Dec 04;10:601072 [PMID: 33344265]
  19. Front Cell Infect Microbiol. 2019 Aug 09;9:276 [PMID: 31448242]
  20. Ann Intern Med. 1979 Apr;90(4):496-9 [PMID: 86311]
  21. Front Cell Infect Microbiol. 2020 Dec 04;10:609812 [PMID: 33344269]
  22. Front Cell Infect Microbiol. 2020 Sep 25;10:429 [PMID: 33102243]
  23. PLoS Pathog. 2009 Dec;5(12):e1000704 [PMID: 20041211]
  24. Front Cell Infect Microbiol. 2019 May 10;9:158 [PMID: 31134163]
  25. J Biol Chem. 2014 Mar 14;289(11):7884-96 [PMID: 24492615]
  26. mBio. 2018 Oct 9;9(5): [PMID: 30301851]
  27. J Exp Med. 1983 Oct 1;158(4):1319-31 [PMID: 6619736]
  28. Lancet. 2016 Jan 23;387(10016):376-385 [PMID: 26231463]
  29. Cell Host Microbe. 2020 Apr 8;27(4):571-584.e7 [PMID: 32220647]
  30. Eur J Clin Microbiol. 1987 Dec;6(6):646-52 [PMID: 2831044]
  31. Front Cell Infect Microbiol. 2020 Sep 23;10:500 [PMID: 33072622]
  32. Nat Rev Microbiol. 2009 Jan;7(1):13-24 [PMID: 19011659]
  33. Front Cell Infect Microbiol. 2020 Feb 13;10:47 [PMID: 32117815]
  34. J Exp Med. 1983 Dec 1;158(6):2108-26 [PMID: 6644240]
  35. Front Cell Infect Microbiol. 2017 Aug 25;7:373 [PMID: 28890882]
  36. FASEB J. 2017 Feb;31(2):663-673 [PMID: 27799347]
  37. Front Cell Infect Microbiol. 2020 Feb 13;10:52 [PMID: 32117818]
  38. Horm Metab Res. 1996 Jun;28(6):267-70 [PMID: 8811326]
  39. Front Cell Infect Microbiol. 2020 Aug 19;10:419 [PMID: 32974215]
  40. Front Cell Infect Microbiol. 2019 Mar 04;9:42 [PMID: 30886834]
  41. J Bacteriol. 2018 Jul 25;200(16): [PMID: 29784886]
  42. Innate Immun. 2016 Apr;22(3):230-7 [PMID: 26873505]
  43. Front Cell Infect Microbiol. 2020 Jun 03;10:238 [PMID: 32582562]
  44. Front Cell Infect Microbiol. 2020 Sep 30;10:511798 [PMID: 33117724]
  45. Clin Infect Dis. 2005 Nov 15;41 Suppl 7:S481-9 [PMID: 16237651]
  46. Trends Microbiol. 1996 Jul;4(7):286-90 [PMID: 8829338]
  47. J Exp Med. 1981 Feb 1;153(2):398-406 [PMID: 7241049]
  48. Genes Dev. 1998 Jan 15;12(2):149-62 [PMID: 9436976]
  49. J Exp Med. 1981 Feb 1;153(2):386-97 [PMID: 7017062]
  50. Proc Natl Acad Sci U S A. 2015 Jun 16;112(24):7557-62 [PMID: 26034289]
  51. J Cell Biol. 2017 Dec 4;216(12):3931-3948 [PMID: 29097627]
  52. Front Cell Infect Microbiol. 2020 Nov 02;10:586934 [PMID: 33330131]
  53. Ann N Y Acad Sci. 1997 Dec 15;832:363-7 [PMID: 9704064]
  54. Front Cell Infect Microbiol. 2020 Jul 07;10:309 [PMID: 32733813]
  55. Front Cell Infect Microbiol. 2020 Nov 20;10:595502 [PMID: 33330138]
  56. Front Cell Infect Microbiol. 2017 Jul 13;7:316 [PMID: 28752080]
  57. Front Cell Infect Microbiol. 2020 Sep 25;10:577559 [PMID: 33102257]
  58. Front Cell Infect Microbiol. 2019 Aug 02;9:279 [PMID: 31428591]
  59. Front Cell Infect Microbiol. 2019 Jul 03;9:241 [PMID: 31334134]
  60. Int Rev Immunol. 2015 Jan;34(1):82-100 [PMID: 25340307]
  61. Am J Clin Pathol. 1980 Apr;73(4):480-7 [PMID: 6989229]
  62. Front Cell Infect Microbiol. 2020 Aug 21;10:448 [PMID: 32974222]
  63. Front Cell Infect Microbiol. 2020 Nov 05;10:599762 [PMID: 33251162]
  64. Immunology. 2015 Feb;144(2):171-85 [PMID: 25262977]
  65. J Immunol. 2009 Oct 1;183(7):4432-9 [PMID: 19748982]
  66. Curr Top Microbiol Immunol. 1998;225:99-112 [PMID: 9386330]
  67. Ann Intern Med. 1979 Apr;90(4):671-5 [PMID: 373550]
  68. Appl Environ Microbiol. 2005 Jan;71(1):20-8 [PMID: 15640165]
  69. Front Cell Infect Microbiol. 2020 Oct 14;10:569070 [PMID: 33163417]
  70. Microb Pathog. 1988 Jul;5(1):41-7 [PMID: 2854187]
  71. APMIS. 1989 Feb;97(2):105-14 [PMID: 2920101]
  72. FEBS Lett. 2013 Jul 11;587(14):2241-6 [PMID: 23735697]
  73. Environ Microbiol. 2000 Jun;2(3):251-65 [PMID: 11200426]
  74. Carbohydr Res. 2012 Mar 1;350:49-54 [PMID: 22277540]
  75. Front Cell Infect Microbiol. 2019 Dec 11;9:421 [PMID: 31921700]
  76. Mucosal Immunol. 2016 May;9(3):718-29 [PMID: 26349661]
  77. Clin Infect Dis. 1993 Jun;16(6):741-7 [PMID: 8329504]
  78. J Leukoc Biol. 2017 Apr;101(4):875-886 [PMID: 28034914]
  79. Infect Immun. 2014 Oct;82(10):4325-36 [PMID: 25092908]
  80. J Leukoc Biol. 1994 Mar;55(3):310-2 [PMID: 8120447]
  81. Front Cell Infect Microbiol. 2020 Nov 10;10:586923 [PMID: 33330130]
  82. Front Cell Infect Microbiol. 2019 Nov 26;9:406 [PMID: 31850239]
  83. Microb Pathog. 1992 Feb;12(2):115-25 [PMID: 1584005]
  84. Chest. 1984 Jan;85(1):114-20 [PMID: 6360569]
  85. PLoS Pathog. 2016 Apr 22;12(4):e1005591 [PMID: 27105352]
  86. Immunol Lett. 2016 Aug;176:81-9 [PMID: 27269375]
  87. J Exp Med. 2016 Jan 11;213(1):15-23 [PMID: 26694970]
  88. Cell. 1984 Jan;36(1):27-33 [PMID: 6692469]
  89. Nat Rev Microbiol. 2017 Oct;15(10):591-605 [PMID: 28713154]
  90. Front Cell Infect Microbiol. 2019 Apr 10;9:97 [PMID: 31024862]
  91. Cell Metab. 2015 Jul 7;22(1):190-190.e1 [PMID: 26154058]
  92. Clin Microbiol Rev. 2002 Jul;15(3):506-26 [PMID: 12097254]
  93. Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14733-40 [PMID: 21873199]
  94. Br J Pharmacol. 2012 Jun;166(3):1169-82 [PMID: 22242942]
  95. Immunity. 2014 Nov 20;41(5):685-93 [PMID: 25517611]
  96. J Leukoc Biol. 2017 Feb;101(2):449-457 [PMID: 27543673]
  97. Inflamm Res. 2012 Jan;61(1):27-35 [PMID: 21947415]
  98. Immunology. 1985 Apr;54(4):643-53 [PMID: 3980045]
  99. Front Cell Infect Microbiol. 2020 Sep 16;10:461 [PMID: 33042857]
  100. Front Cell Infect Microbiol. 2020 Sep 18;10:576596 [PMID: 33072629]
  101. Arch Pathol Lab Med. 1978 Jul;102(7):337-43 [PMID: 580865]
  102. Semin Immunol. 2017 Oct;33:37-43 [PMID: 29042027]
  103. Front Cell Infect Microbiol. 2020 Jun 12;10:287 [PMID: 32596169]
  104. Mol Cell Biol. 2013 Jun;33(12):2425-35 [PMID: 23572562]
  105. J Pathol. 1983 Mar;139(3):349-62 [PMID: 6834178]
  106. Front Cell Infect Microbiol. 2020 Dec 17;10:606541 [PMID: 33392110]
  107. Front Cell Infect Microbiol. 2020 Dec 14;10:595301 [PMID: 33425780]
  108. J Biol Chem. 2018 May 11;293(19):7089-7098 [PMID: 29483195]
  109. J Med Microbiol. 2001 Jun;50(6):517-525 [PMID: 11393289]

Grants

  1. R01 AI140195/NIAID NIH HHS
  2. R21 AI142727/NIAID NIH HHS

MeSH Term

Bacterial Proteins
Cytosol
Glycogen
Glycolysis
Humans
Legionella pneumophila
Legionnaires' Disease
Neutrophils
Phagosomes
Reactive Oxygen Species
Type IV Secretion Systems

Chemicals

Bacterial Proteins
Reactive Oxygen Species
Type IV Secretion Systems
Glycogen

Word Cloud

Created with Highcharts 10.0.0pneumophilarapidLmacrophagesPMNswithinneutrophilsDot/IcmsystemLegionellapathogenshowrespondrestrictionamylasereactiveoxygenspeciesalveolarintracellularcontrastpolymorphonuclearfunctionalLamAeffectorglycogenleadingNeutrophilsglycolysisactivatedphagosomeLCPfusiongranulesmajormechanismskillingtypeIVsecretionT4SSessentiallysosomalevasionpermissivenessproliferationcellsSpecificallyT4SS-injectedcatalyzesdegradationcytosolcytosolichyperglucoseimmunometabolicreprogrammingincludesupregulatedaerobicbecomespatialgeneration-containingspecificazurophilicconcludespecificallyeffectinjectedengagementmicrobicidalprocessescommonlyfoundaquaticenvironmentsresideswidevarietyamoebalhostsUponaerosoltransmissionhumansinvadesreplicatescausingpneumoniadesignatedLegionnaires'diseaseadditioninfiltratelungsinfectedpatientsUnlikerestrictkillpreviouslyunclearsecretesenzymerapidlybreakdownsstorestriggersincreasedSubsequentlytwogranuleproductionresultingDot/Icm-DependentRestrictionleukocytes

Similar Articles

Cited By